Matches in Nanopublications for { ?s ?p "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- _5 value "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" provenance.
- _5 value "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" provenance.
- _5 value "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" provenance.
- _5 value "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" provenance.
- _5 value "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" provenance.
- _5 value "# Ariadne: Activation of RXR, the partner of PPARgamma, in the presence of rosiglitazone, increased further p85alpha PI-3K and UCP2 mRNA levels and produced a significant augmentation of Glut 4 expression. [Regulation]" provenance.